Author

Alok Ranjan

Stanford UniversityORCID 0000-0001-9906-4044Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:electronic health records· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Anjie ZheniD· 1 shared Brian H. YuiD· 1 shared Daniel M. RosenbaumiD· 1 shared Jasmine HeuiD· 1 shared Jef K. De BrabanderiD· 1 shared Jose A. MoraniD· 1 shared Matthew D. MarsdeniD· 1 shared Meghan HaireiD· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Anjie ZhenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Leveraging HIV-Specific CAR T Cells and Rapamycin Treatment in Kick-and-Kill HIV Cure Approaches

Nishad S. Maggirwar, Jose A. Moran, Wenli Mu, Thomas D. Zaikos, Tessa C. Chou, Shireen R. Turner, Brian H. Yu, Alok Ranjan, Rami Hourani, Paul A. Wender, Anjie Zhen, Matthew D. Marsden

This paper demonstrates that combining HIV-specific CAR T cells with rapamycin and latency reversing agents can reduce immune exhaustion and effectively target HIV-infected cells.

bioRxiv · Jan 15, 2026 · PreprintImmunology

Evaluation of the Efficacy of the Hypocretin/orexin Receptor Agonists TAK-925 and ARN-776 in Narcoleptic Orexin/tTA; TetO-DTA Mice

Yu Sun, Alok Ranjan, Ryan K. Tisdale, Shun‐Chieh Ma, Sunmee Park, Meghan Haire, Jasmine Heu, Stephen R. Morairty, Xiaoyu Wang, Daniel M. Rosenbaum, Noelle Sevilir Williams, Jef K. De Brabander, Thomas S. Kilduff

This study evaluates the efficacy of TAK-925 and ARN-776, HCRTR2 agonists, in reducing cataplexy and promoting wakefulness in narcoleptic mice.

bioRxiv · Dec 9, 2022 · PreprintNeuroscience